These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3479417)

  • 1. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.
    Soriano F; Ponte C; Santamaría M; Torres A; Fernández-Roblas R
    J Antimicrob Chemother; 1987 Sep; 20(3):349-55. PubMed ID: 3479417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
    Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.
    Soriano F; Ponte C; Santamaria M; Aguado JM; Wilhelmi I; Vela R; Delatte LC
    J Clin Microbiol; 1985 May; 21(5):788-92. PubMed ID: 3998111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.
    Torres A; Fernández-Roblas R; Méndez B; Soriano F
    Infection; 1986; 14 Suppl 4():S233-6. PubMed ID: 3469152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Corynebacterium group D2.
    Santamaría M; Ponte C; Wilhelmi I; Soriano F
    Antimicrob Agents Chemother; 1985 Dec; 28(6):845-6. PubMed ID: 4083869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ
    Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.
    Fernández-Roblas R; Prieto S; Santamaría M; Ponte C; Soriano F
    Antimicrob Agents Chemother; 1987 May; 31(5):821-2. PubMed ID: 3606082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
    Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
    J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Struvite crystal formation by Corynebacterium group D2 in human urine and its prevention by acetohydroxamic acid.
    Soriano F; Ponte C; Santamaría M; Fernández-Roblas R
    Eur Urol; 1987; 13(4):271-3. PubMed ID: 3653169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
    Muñoz-Bellido JL; Muñoz-Criado S; García-Rodríguez JA
    J Antimicrob Chemother; 1996 May; 37(5):1005-9. PubMed ID: 8737151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.
    García-Rodriguez JA; García Sánchez JE; Muñoz Bellido JL; Nebreda Mayoral T; García Sánchez E; García García I
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2140-3. PubMed ID: 1759839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.
    Philippon A; Bimet F
    Eur J Clin Microbiol Infect Dis; 1990 Dec; 9(12):892-5. PubMed ID: 2073900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
    Verbist L
    J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.